Application Sponsors
ANDA 207313 | MAYNE PHARMA INC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 300MG;50MG | 0 | BUTALBITAL AND ACETAMINOPHEN | ACETAMINOPHEN; BUTALBITAL |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-12-27 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
MAYNE PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 207313
[companyName] => MAYNE PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"BUTALBITAL AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; BUTALBITAL","strength":"300MG;50MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/27\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-12-27
)
)